Skip to main content
. 2024 Mar 5;25:25. doi: 10.1186/s40360-024-00746-6

Fig. 3.

Fig. 3

Evaluation of standard anticancer agents. (a-b) Bliss scores calculated after treatment with the validation drug panel and dexamethasone at 1µM for 72 h in HCT116-GFP (a) and A549-NLR (b). Data shown as mean ± SEM from three independent experiments. (c-d) Bliss scores (x-axis) plotted against the viability in PBMC monocultures (y-axis) after treatment with the validation drug panel at 1µM for 72 h in HCT116-GFP (c) and A549-NLR (d). Data shown as means from three independent experiments